Trials / Unknown
UnknownNCT00573573
Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism
Phase 1 Study to Evaluate the Efficacy of Using Energy Specific Far Infrared Radiation Treatment for Hyperparathyroidism.
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 2 (estimated)
- Sponsor
- GAAD Medical Research Institute Inc. · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
A study to determine the possibility of using far infrared radiation to treat Hyperparathyroidism.
Detailed description
Overactive parathyroid glands secrete an excess of parathyroid hormones, resulting in increased levels of calcium in the blood stream, which can lead to weakening of the bones and to kidney stones. We are postulating that the non-invasive energy specific electromagnetic radiation of the central nervous system, the viscera and the endocrine system has the potential to stop the over secretion of the parathyroid hormones and normalize the body's metabolic functions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Far Infrared Radiation | Far Infrared Radiation (5μm to 20μm wavelength) for 30 to 40 minutes each session. |
Timeline
- Start date
- 2007-01-01
- Primary completion
- 2009-03-01
- Completion
- 2009-07-01
- First posted
- 2007-12-14
- Last updated
- 2009-03-24
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT00573573. Inclusion in this directory is not an endorsement.